Breast implants: sensation can change

More choice in implant size does not answer every question about breast augmentation. NewBeauty’s 20 October coverage foregrounded a subtler appearance. The FDA record dates its approval of smaller Motiva devices to 2 October 2026; the manufacturer’s announcement followed on 5 October. This is a documented product-range development. It does not establish that smaller implants preserve sensation better.

That distinction matters because breast shape and breast sensation are different outcomes. A photograph can show contour; it cannot establish whether touch at the nipple or surrounding skin feels the same. A systematic review published in JPRAS Open on 29 September 2026 brings that less visible question into focus, without delivering a dependable ranking of surgical techniques.

Recovery is a pattern, not a promise

The authors report 26 studies involving 9,190 patients undergoing primary cosmetic breast augmentation. Most reported sensory changes were temporary, with recovery commonly described within 6–12 months. But some studies found persistent changes, and the review does not supply a reliable overall probability of lasting sensory loss. Its findings concern first-time implant augmentation, not reconstruction, implant revision or breast lifting.

The way sensation was measured makes a substantial difference. Some researchers tested pressure or vibration thresholds; others relied on questionnaires or routine clinical reports. Measurable changes did not always correspond to what patients felt. These approaches capture different aspects of an outcome that can matter in everyday life and intimacy.

Why percentages cannot choose an incision

For studies with usable counts, the review reports sensory changes in 73 of 904 patients with incisions around the areola, approximately 8.1%, versus 124 of 5,905 with incisions in the breast fold, approximately 2.1%. These are simple descriptive totals across different studies, not a meta-analysis or a randomized head-to-head estimate. Differences in patients, follow-up and testing prevent treating them as personal risk figures or proof that an incision caused the difference.

The same caution applies to implant position. Several reports favored deeper placement, but findings differed by the breast region tested. Implant volume had an inconsistent association with sensation. The review does not establish a size threshold below which sensory changes disappear, nor does it validate the newly approved product sizes.

Two large cohorts carried much of the numerical weight while using nonstandard sensory reporting, which may miss subtler changes. The mostly observational evidence and absence of a prospectively registered review protocol further limit certainty.

A fuller definition of the result

The useful implication is to assess sensation alongside shape: what was measured before surgery, which area changed, and how recovery was followed. More consistent testing combined with patients’ own reports would make comparisons more useful. A smaller-looking result and unchanged sensation remain separate questions.